Apogee Therapeutics Inc Stock Ownership - Who owns Apogee Therapeutics?

Insider buying vs selling

Have Apogee Therapeutics Inc insiders been buying or selling?
Fairmount Funds Management LLCDirector2023-07-13892,529$17.00
Fairmount Funds Management LLCDirector2023-07-131,992,734$17.00
Fairmount Funds Management LLCDirector2023-07-1355,913$17.00
Nimish P. ShahDirector2023-07-131,750,000$17.00

1 of 1

APGE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APGE insiders and whales buy or sell their stock.

APGE Shareholders

What type of owners hold Apogee Therapeutics Inc stock?
Vr Adviser LLC14.53%8,493,321$322.75MInstitution
Fmr LLC11.54%6,743,902$256.27MInstitution
Blackrock Inc4.81%2,809,825$106.77MInstitution
Perceptive Advisors LLC4.62%2,699,345$102.58MInstitution
Rtw Investments LP4.22%2,467,591$93.77MInstitution
Deep Track Capital LP3.97%2,323,456$88.29MInstitution
Wellington Management Group LLP3.88%2,269,897$86.26MInstitution
Fairmount Funds Management LLC3.68%2,150,979$81.74MInsider
Driehaus Capital Management LLC3.53%2,063,763$78.42MInstitution
Fairmount Funds Management LLC3.50%2,048,647$77.85MInstitution

1 of 3

APGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APGE89.97%10.03%Net Buying
IOVA16.63%83.37%Net BuyingNet Selling
VCEL91.08%8.92%Net SellingNet Buying
JANX50.09%49.91%Net SellingNet Selling
GPCR31.20%14.74%Net BuyingNet Buying

Apogee Therapeutics Stock Ownership FAQ

Who owns Apogee Therapeutics?

Apogee Therapeutics (NASDAQ: APGE) is owned by 91.59% institutional shareholders, 10.21% Apogee Therapeutics insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Apogee Therapeutics shareholder, owning 2.15M shares representing 3.68% of the company. Fairmount Funds Management LLC's Apogee Therapeutics shares are currently valued at $81.74M.

If you're new to stock investing, here's how to buy Apogee Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.